Brief: HBM Holdings Reports Advancement Of Global Collaboration With Astrazeneca
24/11/2025 01:45
Nov 24 (Reuters) - Hbm Holdings Ltd 2142.HK: ADVANCEMENT OF GLOBAL COLLABORATION WITH ASTRAZENECA SCOPE OF COLLABORATION FURTHER ADVANCED AIMING TO DISCOVER AND DEVELOP NEXT-GENERATION BIOTHERAPEUTICS, OTHERS Further company coverage: 2142.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study